Peter Maybarduk

Peter Maybarduk

Peter Maybarduk is Public Citizen's Global Access to Medicines Program Director. Maybarduk helps governments and civil society groups around the world use flexibilities in patent and trade rules to promote access to medicines for all. For example, Maybarduk's recent work with partners yielded major HIV/AIDS drug price reductions in Colombia and new state access to medicines policies enacted by the President of Ecuador. His work also focuses on protecting competition and access under intellectual property enforcement policies, and on appropriate policy responses to criminally adulterated or falsified medicines. Maybarduk has co-founded and coordinated several volunteer-run advocacy and assistance groups, including International Professional Partnerships for Sierra Leone (IPPSL), dedicated to supporting public sector development in one of the world's least developed countries. He studied law at the University of California at Berkeley and anthropology at the College of William and Mary. Maybarduk is a composer and performer of music, currently recording his third album with producer J. Robbins.

New TPP Maneuvering on Biologics, But 5+3 Still = 8

Ministerial talks for the Trans-Pacific Partnership (TPP) collapsed in Maui last month when trade ministers sparred over issues including monopolies for biotech drugs, which include many cancer treatments. Talks resumed this weekend in Atlanta, where negotiators are reportedly exploring a…

Resist the Special 301 Watch List

The Office of the US Trade Representative’s 2014 Special 301 Report is expected out shortly.  The 301 Report places countries on a watch list for practices the US Government believes reflect “inadequate” intellectual property protection, even when these policies protect…

“Heavy-handed” TPP tactics from US Trade Rep

[Reposted from the citizenvox blog.] The Trans-Pacific Partnership (TPP) is a massive package of proposed new economic rules for the Asia-Pacific region (including the US), heavily influenced by corporate priorities through the Office of the United States Trade Representative (USTR)…